Definitive Contract 75N92020C00027
Award Date
8/28/20
Potential Completion Date
8/27/21
Potential Value
$21M
Federal Agency
National Heart Lung and Blood Institute
Awardee
Sonic Healthcare USA Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Austin, TX 78727, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Aegis Sciences Corporation was awarded a firm fixed price definitive contract valued at $17,982,063.34 by the National Institutes of Health's National Heart, Lung and Blood Institute to rapidly develop SARS-CoV-2 test capacity as part of the RADx program. Under the contract, Aegis Sciences, doing business as Aegis Analytical Laboratories in Nashville, Tennessee, will deliver testing services from August 2020 through August 2022 to support the National Institutes of Health's efforts to accelerate...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $14.9 million firm fixed price definitive contract to ADL Diagnostics Inc., doing business as Harmony Diagnostics, to support the development and delivery of a low-cost, moderate-throughput COVID-19 test to enable massive testing scale-up at small clinics and community sites. Performance will take place in Woodinville, Washington through May 2023. The award responds to...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a firm fixed price purchase order contract to Ascella Biosystems Inc., a for-profit manufacturer, on January 13, 2021. The $250,000.00 contract is for RADX-TECH - SUPPORT SERVICES NEEDED FOR WORK PACKAGE 1 and is associated with the Coronavirus COVID-19 national interest action. The contract does not have a set-aside designation and is scheduled for completion on January...
Helix Opco, LLC was awarded a definitive contract valued at $45.9 million by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to support the Rapid Acceleration of Diagnostics (RADX) Advanced Technologies Platform. The firm fixed price contract runs from July 2020 through October 2022 and calls for Helix Opco to provide services in support of the RADX program, which aims to accelerate the development, commercialization, and...
The Department of Health and Human Services National Institutes of Health National Institute of Biomedical Imaging and Bioengineering awarded a $20.7 million firm fixed price definitive contract to Associated Pathologists, LLC (doing business as Pathgroup) for the Rapid Acceleration of Diagnostics (RADX) ATP Program - Project #7338. The contract is being funded under the Coronavirus COVID-19 national interest action code and will support RADX's goal of accelerating the development,...
The National Institutes of Health's National Heart, Lung and Blood Institute awarded an $18.2 million firm fixed price definitive contract to Quanterix Corporation as part of the Rapid Acceleration of Diagnostics initiative. The RADx program aims to expedite the development, commercialization, and implementation of Covid-19 testing technologies to significantly increase domestic testing capacity. Quanterix will support this objective through the delivery of diagnostic solutions over a two-year...
The Broad Institute, Inc., doing business as the Broad Institute of MIT and Harvard, has been awarded a definitive contract valued at $25.7 million by the National Institutes of Health's National Heart, Lung and Blood Institute to scale the Broad Institute's reverse transcription polymerase chain reaction (RT-PCR) process to support testing of over 100,000 samples per day. This contract is part of the Rapid Acceleration of Diagnostics (RADx) Advanced Technology Platforms program, which aims to...
This is a firm fixed-price federal contract awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Illumina, Inc. The contract, valued at $87,365.00, is for the rapid establishment of a massively scaled next-generation sequencing (NGS) laboratory to support COVID-19 testing in the United States. This contract was awarded under the RAPID ACCELERATION OF DIAGNOSTICS (RADX) program, which aims to speed the development, validation, and...
The U.S. National Institute of Biomedical Imaging and Bioengineering, part of the Department of Health and Human Services, awarded a $16,239,965.00 firm fixed price contract to Mologic Inc., a foreign-owned for-profit organization, for the Rapid Acceleration of Diagnostics (RADx) Program Tech Project #7697: SARS-CoV-2 Antigen Home Test. This contract, which does not have a set-aside designation, aims to deliver the testing products through January 2025 from Mologic's facility in Bedford, New...
<p>The National Heart, Lung and Blood Institute, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a definitive contract valued at $1,099,350.00 to Rosalind, Inc. for Rapid Acceleration of Diagnostics technology. Rosalind, Inc. will perform all work at its division location in Bethesda, Maryland under firm fixed pricing from December 5, 2022 through December 4, 2023. No subcontractors were identified.</p>